Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gergely Toth currently holds 23,432,088 shares of Cantabio Pharmaceuticals Inc. (CTBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gergely Toth has been a net neutral trader of CTBO stock. They have purchased $0 and sold $0 worth of shares.
Gergely Toth's most recent insider trade was on Sep 12, 2018, when they sold 7,352,941 shares at $0.00 per share.
Gergely Toth serves as Executive at Cantabio Pharmaceuticals Inc. (CTBO). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Gergely Toth holds the position of Executive at Cantabio Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Gergely Toth has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gergely Toth was on Sep 12, 2018, when they purchased $0 worth of CTBO shares. This transaction involved 7,352,941 shares at N/A per share.
Gergely Toth currently owns 23,432,088 shares of Cantabio Pharmaceuticals Inc. (CTBO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gergely Toth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gergely Toth has 5 Form 4 filings on record as an insider at Cantabio Pharmaceuticals Inc..
Set alerts for Gergely Toth and 40,000+ other insiders.